Cargando…

M195. LATENT STRUCTURE OF NEGATIVE SYMPTOMS IN EARLY PSYCHOSIS AND CLINICAL HIGH-RISK FOR PSYCHOSIS

BACKGROUND: Negative symptoms are prevalent and predictive of clinical and functional outcomes across different phases of psychotic disorders. Yet, heterogeneity in conceptualizing the latent structure of negative symptoms presents hindrances to the development of effective interventions. While a 2-...

Descripción completa

Detalles Bibliográficos
Autores principales: Chi Yiu Wong, Sandra, Kwun Nam Chan, Joe, Strauss, Gregory P, Ahmed, Anthony O, Sau Man Wong, Corine, Ming Hui, Lai, Wa Chan, Kit, Ming Lee, Ho, Nam Suen, Yi, Chen, Eric, Chung Chang, Wing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7234437/
http://dx.doi.org/10.1093/schbul/sbaa030.507
_version_ 1783535762675859456
author Chi Yiu Wong, Sandra
Kwun Nam Chan, Joe
Strauss, Gregory P
Ahmed, Anthony O
Sau Man Wong, Corine
Ming Hui, Lai
Wa Chan, Kit
Ming Lee, Ho
Nam Suen, Yi
Chen, Eric
Chung Chang, Wing
author_facet Chi Yiu Wong, Sandra
Kwun Nam Chan, Joe
Strauss, Gregory P
Ahmed, Anthony O
Sau Man Wong, Corine
Ming Hui, Lai
Wa Chan, Kit
Ming Lee, Ho
Nam Suen, Yi
Chen, Eric
Chung Chang, Wing
author_sort Chi Yiu Wong, Sandra
collection PubMed
description BACKGROUND: Negative symptoms are prevalent and predictive of clinical and functional outcomes across different phases of psychotic disorders. Yet, heterogeneity in conceptualizing the latent structure of negative symptoms presents hindrances to the development of effective interventions. While a 2-dimensional construct of negative symptoms (i.e., Motivation and pleasure [MAP] and Emotional expressivity [EXP] dimensions) have previously been derived from exploratory factor analyses and adopted widely in research, conflicting findings in favor of a 5-factor structure have emerged from confirmatory factor analyses recently. Further evidence is needed to evaluate whether this conclusion can be generalized to the prodromal and early phases of psychosis. METHODS: Data were drawn from 3 studies that administered the Brief Negative Symptom Scale (BNSS), a second-generation clinical rating instrument, to assess negative symptoms in Chinese patients with early psychosis or clinical high-risk for psychosis (CHR) in Hong Kong. The early psychosis sample comprised 131 and 246 outpatients recruited in 2 separate studies who received treatment within 5 years since service entry for first-episode psychosis, whereas the CHR sample included 110 help-seeking individuals ascertained using CAARMS criteria. Confirmatory factor analyses (CFAs) were employed to examine competing hypotheses about the factor structure of negative symptoms as measured by BNSS. The fit of five competing models were evaluated, including 1) a unifactorial model, 2) a 2-factor model with EXP and MAP factors, 3) a 3-factor model proposed by Garcia-Portilla et al. (anhedonia and asociality, avolition and blunted affect, and alogia), 4) a 5-factor model specifying the five NIMH consensus development conference domains (blunted affect, alogia, anhedonia, avolition, asociality), and 5) a hierarchical model with two second order-factors reflecting EXP and MAP, and five first-order factors reflecting the five consensus domains. RESULTS: In the early psychosis sample, the 1-, 2-, and 3-factor models provided poor fit for the data. The 5-factor and hierarchical models were excellent fit, with the hierarchical model being slightly more parsimonious. Similarly, CFA of the CHR sample demonstrated that the 1-, 2-, and 3-factor models were poor fit for the BNSS, whereas the 5-factor and hierarchical models provided strong fit. The 5-factor model is slightly favored over the hierarchical model in the CHR sample. DISCUSSION: Similar to results obtained from chronic schizophrenia patients in previous CFA studies, the current findings suggest that the 5 consensus domains are fundamental to the conceptualization of negative symptoms in the prodromal and early phases of psychosis. The current practice of conceptualizing negative symptoms as a two-dimensional construct may preclude information that reflects the narrower facets of idiosyncratic symptom profiles and facilitates functional recovery.
format Online
Article
Text
id pubmed-7234437
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-72344372020-05-23 M195. LATENT STRUCTURE OF NEGATIVE SYMPTOMS IN EARLY PSYCHOSIS AND CLINICAL HIGH-RISK FOR PSYCHOSIS Chi Yiu Wong, Sandra Kwun Nam Chan, Joe Strauss, Gregory P Ahmed, Anthony O Sau Man Wong, Corine Ming Hui, Lai Wa Chan, Kit Ming Lee, Ho Nam Suen, Yi Chen, Eric Chung Chang, Wing Schizophr Bull Poster Session II BACKGROUND: Negative symptoms are prevalent and predictive of clinical and functional outcomes across different phases of psychotic disorders. Yet, heterogeneity in conceptualizing the latent structure of negative symptoms presents hindrances to the development of effective interventions. While a 2-dimensional construct of negative symptoms (i.e., Motivation and pleasure [MAP] and Emotional expressivity [EXP] dimensions) have previously been derived from exploratory factor analyses and adopted widely in research, conflicting findings in favor of a 5-factor structure have emerged from confirmatory factor analyses recently. Further evidence is needed to evaluate whether this conclusion can be generalized to the prodromal and early phases of psychosis. METHODS: Data were drawn from 3 studies that administered the Brief Negative Symptom Scale (BNSS), a second-generation clinical rating instrument, to assess negative symptoms in Chinese patients with early psychosis or clinical high-risk for psychosis (CHR) in Hong Kong. The early psychosis sample comprised 131 and 246 outpatients recruited in 2 separate studies who received treatment within 5 years since service entry for first-episode psychosis, whereas the CHR sample included 110 help-seeking individuals ascertained using CAARMS criteria. Confirmatory factor analyses (CFAs) were employed to examine competing hypotheses about the factor structure of negative symptoms as measured by BNSS. The fit of five competing models were evaluated, including 1) a unifactorial model, 2) a 2-factor model with EXP and MAP factors, 3) a 3-factor model proposed by Garcia-Portilla et al. (anhedonia and asociality, avolition and blunted affect, and alogia), 4) a 5-factor model specifying the five NIMH consensus development conference domains (blunted affect, alogia, anhedonia, avolition, asociality), and 5) a hierarchical model with two second order-factors reflecting EXP and MAP, and five first-order factors reflecting the five consensus domains. RESULTS: In the early psychosis sample, the 1-, 2-, and 3-factor models provided poor fit for the data. The 5-factor and hierarchical models were excellent fit, with the hierarchical model being slightly more parsimonious. Similarly, CFA of the CHR sample demonstrated that the 1-, 2-, and 3-factor models were poor fit for the BNSS, whereas the 5-factor and hierarchical models provided strong fit. The 5-factor model is slightly favored over the hierarchical model in the CHR sample. DISCUSSION: Similar to results obtained from chronic schizophrenia patients in previous CFA studies, the current findings suggest that the 5 consensus domains are fundamental to the conceptualization of negative symptoms in the prodromal and early phases of psychosis. The current practice of conceptualizing negative symptoms as a two-dimensional construct may preclude information that reflects the narrower facets of idiosyncratic symptom profiles and facilitates functional recovery. Oxford University Press 2020-05 2020-05-18 /pmc/articles/PMC7234437/ http://dx.doi.org/10.1093/schbul/sbaa030.507 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Poster Session II
Chi Yiu Wong, Sandra
Kwun Nam Chan, Joe
Strauss, Gregory P
Ahmed, Anthony O
Sau Man Wong, Corine
Ming Hui, Lai
Wa Chan, Kit
Ming Lee, Ho
Nam Suen, Yi
Chen, Eric
Chung Chang, Wing
M195. LATENT STRUCTURE OF NEGATIVE SYMPTOMS IN EARLY PSYCHOSIS AND CLINICAL HIGH-RISK FOR PSYCHOSIS
title M195. LATENT STRUCTURE OF NEGATIVE SYMPTOMS IN EARLY PSYCHOSIS AND CLINICAL HIGH-RISK FOR PSYCHOSIS
title_full M195. LATENT STRUCTURE OF NEGATIVE SYMPTOMS IN EARLY PSYCHOSIS AND CLINICAL HIGH-RISK FOR PSYCHOSIS
title_fullStr M195. LATENT STRUCTURE OF NEGATIVE SYMPTOMS IN EARLY PSYCHOSIS AND CLINICAL HIGH-RISK FOR PSYCHOSIS
title_full_unstemmed M195. LATENT STRUCTURE OF NEGATIVE SYMPTOMS IN EARLY PSYCHOSIS AND CLINICAL HIGH-RISK FOR PSYCHOSIS
title_short M195. LATENT STRUCTURE OF NEGATIVE SYMPTOMS IN EARLY PSYCHOSIS AND CLINICAL HIGH-RISK FOR PSYCHOSIS
title_sort m195. latent structure of negative symptoms in early psychosis and clinical high-risk for psychosis
topic Poster Session II
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7234437/
http://dx.doi.org/10.1093/schbul/sbaa030.507
work_keys_str_mv AT chiyiuwongsandra m195latentstructureofnegativesymptomsinearlypsychosisandclinicalhighriskforpsychosis
AT kwunnamchanjoe m195latentstructureofnegativesymptomsinearlypsychosisandclinicalhighriskforpsychosis
AT straussgregoryp m195latentstructureofnegativesymptomsinearlypsychosisandclinicalhighriskforpsychosis
AT ahmedanthonyo m195latentstructureofnegativesymptomsinearlypsychosisandclinicalhighriskforpsychosis
AT saumanwongcorine m195latentstructureofnegativesymptomsinearlypsychosisandclinicalhighriskforpsychosis
AT minghuilai m195latentstructureofnegativesymptomsinearlypsychosisandclinicalhighriskforpsychosis
AT wachankit m195latentstructureofnegativesymptomsinearlypsychosisandclinicalhighriskforpsychosis
AT mingleeho m195latentstructureofnegativesymptomsinearlypsychosisandclinicalhighriskforpsychosis
AT namsuenyi m195latentstructureofnegativesymptomsinearlypsychosisandclinicalhighriskforpsychosis
AT cheneric m195latentstructureofnegativesymptomsinearlypsychosisandclinicalhighriskforpsychosis
AT chungchangwing m195latentstructureofnegativesymptomsinearlypsychosisandclinicalhighriskforpsychosis